Literature DB >> 7772363

Risk of high spinal anesthesia following failed epidural block for cesarean delivery.

S R Furst1, L S Reisner.   

Abstract

Recent case reports suggest there may be an increased risk of abnormally high blockade ("high spinal") from subarachnoid anesthesia if it is performed immediately after epidural anesthesia. We describe two cases of high spinal anesthesia following failed epidural block in obstetric patients scheduled for cesarean delivery. Using a retrospective chart review, we estimate the incidence of high spinal anesthesia to be 11% in patients after prior failed epidural blockade versus fewer than 1% in patients undergoing spinal anesthesia alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7772363     DOI: 10.1016/0952-8180(94)00020-5

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  5 in total

1.  Total spinal block after spinal anesthesia following ongoing epidural analgesia for cesarean delivery.

Authors:  Sahar M Siddik-Sayyid; Pamela H Gellad; Marie T Aouad
Journal:  J Anesth       Date:  2011-12-10       Impact factor: 2.078

2.  A Rare Case of C2 Sensory Blockade with Preserved Phrenic Nerve Function in an Obstetric Patient.

Authors:  John C Coffman; Kasey Fiorini; Meghan Cook; Robert H Small
Journal:  Case Rep Anesthesiol       Date:  2016-07-31

3.  Suspected total spinal in patient having emergent Caesarean section, a case report and literature review.

Authors:  H Virgin; E Oddby; J G Jakobsson
Journal:  Int J Surg Case Rep       Date:  2016-10-03

4.  Labor Epidural Analgesia to Cesarean Section Anesthetic Conversion Failure: A National Survey.

Authors:  Neel Desai; Andrew Gardner; Brendan Carvalho
Journal:  Anesthesiol Res Pract       Date:  2019-06-02

5.  Evaluation of failed and high blocks associated with spinal anesthesia for Cesarean delivery following inadequate labour epidural: a retrospective cohort study.

Authors:  Lisa M Einhorn; Ashraf S Habib
Journal:  Can J Anaesth       Date:  2016-07-15       Impact factor: 6.713

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.